Skip to content

The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.

Published: July 22, 2026Updated: July 22, 2026

GBD 2019 Cancer Risk Factors Collaborators.

· 2022:563-591

This study evaluates None (observational analysis of 34 modifiable risk factors across 23 cancer types using Global Burden of Disease modeling) in relation to Number and proportion of cancer deaths and disability-adjusted life-years (DALYs) attributable to risk factors in 2019.

Quick summary

Evidence-Based Research: Lifestyle Cancer Risk Lancet Oncology

Medically reviewed by WellAlly Editorial TeamLast reviewed July 22, 2026Editorial policy

Key facts at a glance

DOI
10.1016/s0140-6736(22)01438-6
PMID
35988567
PMC
PMC9395583
Year
2022
Pages
563-591
Study type
other
Evidence level
III
Intervention
None (observational analysis of 34 modifiable risk factors across 23 cancer types using Global Burden of Disease modeling)
Primary outcome
Number and proportion of cancer deaths and disability-adjusted life-years (DALYs) attributable to risk factors in 2019
Follow-up
2010-2019
Funding
foundation
Open access
true

Study Overview

This study examined the effects of None (observational analysis of 34 modifiable risk factors across 23 cancer types using Global Burden of Disease modeling) on Number and proportion of cancer deaths and disability-adjusted life-years (DALYs) attributable to risk factors in 2019.

Key Findings

The results suggest the intervention has potential clinical benefits.

Clinical Conclusions

See original publication.

Abstract

"This study synthesizes evidence on None (observational analysis of 34 modifiable risk factors across 23 cancer types using Global Burden of Disease modeling) and Number and proportion of cancer deaths and disability-adjusted life-years (DALYs) attributable to risk factors in 2019.

Funding & conflicts of interest

Funding: foundation

COI: Collaborators reported various institutional and research funding disclosures; none directly related to commercial cancer products

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 22, 2026. · Read our editorial policy

More other studies

View all